• Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)
    • Services
      • Equity Reports (Analyst-Ready)
      • Visibility Upgrades (Quartely + As needed)
      • Investor Mapping
    • Press
    • Contact
    • English
      • Deutsch (German)
      • 日本語 (Japanese)
  • info@vasro.net
  • +49 (0)69 90 28 39 81
  • Call us Mon - Fri: 8:30 AM - 6:00 PM
VASRO GmbH
VASRO GmbH
  • Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)

Market Intelligence

VASRO GmbH > Press > Market Intelligence
VASRO GmbH

The Rise of Green Pharma: How Renewable Energy is Transforming the Pharmaceutical Industry

  • April 29, 2025
  • Energy, Pharma & Biotech
Green Pharma is revolutionizing the pharmaceutical industry by using renewable energy to cut emissions, reduce waste, and promote sustainable drug manufacturing.
Continue Reading
VASRO GmbH

The 2025 Surge in Stem-Cell Research and Development

  • April 8, 2025
  • Pharma & Biotech
Stem-cell research resurgence in 2025 is fueled by regulatory reforms, political advocacy, and investments, with biotech firms advancing groundbreaking therapies.
Continue Reading
VASRO GmbH

Private Equity’s Impact on European Tech Recovery and Growth in 2025

  • March 28, 2025
  • Equity Analysis reports
Private equity in European tech is driving recovery in 2025 through innovation, ESG investments, and cross-border deals, overcoming 2024's challenges.
Continue Reading
VASRO GmbH

The Impact of Blackstone’s AirTrunk Acquisition on Digital Infrastructure Growth

  • March 26, 2025
  • Tech
Blackstone's $24B AirTrunk acquisition boosts digital infrastructure, meeting AI and cloud computing demands while positioning Asia-Pacific as a tech innovation hub.
Continue Reading
VASRO GmbH

Key Trends in Private Equity and Technology Mergers for 2025

  • March 25, 2025
  • Tech
Private equity in information technology drives innovation in 2025, shaping M&A trends with AI, SaaS, and digital transformation as key focus areas.
Continue Reading
VASRO GmbH

The Resilience of the European Union’s Tech Sector in 2025

  • March 24, 2025
  • Tech
Explore the resilience of the European Union's tech sector in 2025, highlighting opportunities, challenges, and key companies thriving despite market uncertainties.
Continue Reading
VASRO GmbH

How Private Equity is Transforming High-Tech in 2025

  • March 19, 2025
  • Tech
Private equity in high-tech industries is driving 2025 trends in AI, cybersecurity, and digital infrastructure, reshaping innovation and creating growth opportunities.
Continue Reading
VASRO GmbH

Private equity in technology sector

  • March 13, 2025
  • Tech
Private equity drives innovation in the tech sector by funding AI, SaaS, and cybersecurity, enabling growth, digital transformation, and high-value investments.
Continue Reading

How Market Intelligence Supports Proactive Decision Making

  • December 4, 2024
  • Pharma & Biotech, Tech
Market intelligence for decision making helps businesses analyze data, predict trends, and make proactive, strategic decisions to stay competitive and reduce risks.
Continue Reading

Posts pagination

Previous 1 … 3 4

Search

Categories

  • Energy
  • Equity Analysis reports
  • Equity Research Coverage
  • Market Intelligence
  • Pharma & Biotech
  • Tech
  • Unkategorisiert

Recent Posts

Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace September 11, 2026
Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33 September 7, 2026
Sirnaomics Ltd.: Every Approved siRNA Drug Works in the Liver. This One Was Injected Into Skin Cancer. VASRO Initiates Coverage With BUY September 7, 2026
Zaptec ASA: Europe’s Largest AC Charging Brand, With the Service Layer Priced at Zero – VASRO Initiates Coverage With BUY August 31, 2026
Spinneys 1961 Holding PLC: The Estate Grew 17%, Demand Did Not — First Half 2026 Update August 12, 2026
VASRO GmbH
VASRO GmbH specializes in equity analysis, market intelligence, and investment strategy for the pharmaceutical, biotechnology, and IT sectors. We deliver tailored insights to drive informed investment decisions and achieve exceptional results.

Discover More

Contact Info

  • Am Hauptbahnhof 16, 60329 Frankfurt am Main, Germany
  • +49 (0)69 90 28 39 81
  • Info@vasro.net
  • 8:30 AM - 6:00 PM

Navigation

  • Imprint
  • Privacy Policy
  • Change privacy settings
  • Application
  • About
  • FAQ

©copyright 2025 VASRO GmbH.